Chemical compound
Barusiban ATC code
(4S ,7S ,10S ,13S ,16R )-N -[(2S )-5-Amino-1-hydroxy-2-pentanyl]-7-(2-amino-2-oxoethyl)-10-[(2R )-2-butanyl]-13-sec -butyl-16-(1H -indol-3-ylmethyl)-N -methyl-6,9,12,15,18-pentaoxo-1-thia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
CAS Number PubChem CID ChemSpider UNII CompTox Dashboard (EPA ) DTXSID20182771 Formula C 40 H 63 N 9 O 8 S Molar mass 830.06 g·mol−1 3D model (JSmol)
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCSCCC(=O)N[C@@H](C(=O)N1)CC2=CNC3=CC=CC=C32)C(=O)N(C)[C@@H](CCCN)CO)CC(=O)N)[C@H](C)CC
InChI=1S/C40H63N9O8S/c1-6-23(3)34-38(55)46-31(20-32(42)51)36(53)45-29(40(57)49(5)26(22-50)11-10-16-41)14-17-58-18-15-33(52)44-30(19-25-21-43-28-13-9-8-12-27(25)28)37(54)47-35(24(4)7-2)39(56)48-34/h8-9,12-13,21,23-24,26,29-31,34-35,43,50H,6-7,10-11,14-20,22,41H2,1-5H3,(H2,42,51)(H,44,52)(H,45,53)(H,46,55)(H,47,54)(H,48,56)/t23-,24+,26+,29+,30-,31+,34+,35+/m1/s1
Key:UGNGRKKDUVKQDF-IHOMMZCZSA-N
Barusiban (INN) (code name FE-200440 ) is a non-peptide drug which is among the most potent and selective oxytocin receptor antagonists known.[1] [2] It was trialed by Ferring Pharmaceuticals as a treatment of preterm labor but failed to demonstrate effectiveness and was not pursued any further.[1] [3]
^ a b Landgraf R, Neumann ID (10 September 2008). Advances in Vasopressin and Oxytocin - From Genes to Behaviour to Disease . Elsevier. pp. 194, 489. ISBN 978-0-08-093247-7 .
^ Offermanns S, Rosenthal W (14 August 2008). Encyclopedia of Molecular Pharmacology . Springer Science & Business Media. pp. 1278–. ISBN 978-3-540-38916-3 .
^ Ouellette R, Joyce J (25 October 2010). Pharmacology for Nurse Anesthesiology . Jones & Bartlett Publishers. pp. 450–. ISBN 978-0-7637-8607-6 .
Last Update: 2023-12-19T16:33:52Z
Barusiban (INN) (code name FE-200440) is a non-peptide drug which is among the most potent and selective oxytocin receptor antagonists known. It was trialed...
Word Count : 126
Last Update: 2024-02-03T05:27:53Z
effects are longer lasting than other oxytocin homologs such as oxytocin or barusiban . A single carbetocin dose compared to a placebo or an eight-hour intravenous...
Word Count : 1913
Last Update: 2024-05-18T16:05:08Z
WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662 Nolasiban...
Word Count : 11642
Last Update: 2024-05-20T06:32:19Z
preterm childbirth. A few tocolytic alternatives worth pursuing include Barusiban , a last generation of oxytocin receptor antagonists, as well as COX-2...
Word Count : 2486
Last Update: 2024-03-24T10:12:49Z
WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662 Nolasiban...
Word Count : 3871
Last Update: 2023-11-07T18:20:30Z
WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662 Nolasiban...
Word Count : 1518
Last Update: 2024-05-20T07:47:20Z
WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662 Nolasiban...
Word Count : 1724
Last Update: 2023-07-06T09:37:08Z
WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662 Nolasiban...
Word Count : 264
Last Update: 2024-03-08T08:21:09Z
WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662 Nolasiban...
Word Count : 584
Last Update: 2024-05-09T08:21:55Z
mice; possibly non-selective over vasopressin receptors Peptide Atosiban Barusiban Non-peptide Epelsiban L-368,899 (CAS# 148927-60-0) L-371,257 (CAS# 162042-44-6)...
Word Count : 2492
Last Update: 2024-05-19T06:48:08Z
WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662 Nolasiban...
Word Count : 2466
Last Update: 2024-05-15T00:01:04Z
WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662 Nolasiban...
Word Count : 2321
Last Update: 2024-05-15T08:44:09Z
WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662 Nolasiban...
Word Count : 763
Last Update: 2024-03-10T03:10:57Z
WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662 Nolasiban...
Word Count : 974
Last Update: 2023-08-27T06:01:00Z
WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662 Nolasiban...
Word Count : 1361
Last Update: 2024-01-07T19:46:05Z
WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662 Nolasiban...
Word Count : 3516
Last Update: 2022-11-05T00:15:18Z
WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662 Nolasiban...
Word Count : 72
Last Update: 2022-12-09T10:03:59Z
WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662 Nolasiban...
Word Count : 805
Last Update: 2024-02-11T10:45:52Z
WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662 Nolasiban...
Word Count : 1043
Last Update: 2024-03-12T22:03:04Z
WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662 Nolasiban...
Word Count : 1057
Last Update: 2024-01-04T11:59:15Z
WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662 Nolasiban...
Word Count : 1740
Last Update: 2023-08-13T07:58:13Z
WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662 Nolasiban...
Word Count : 122